Websites hosted on 206.16.26.136
Server (IP 206.16.26.136) has hosted these websites/domains at one point or another.
Number of websites/domains displayed: 22
Results found: 22
Websites discovered:
Registrationhttp://pageoverview.com/website-report/vyvansesavings.com
- Expected expiration: June 18th in 2017
- Creation date: June 18th in 2010
- Renew date: May 22nd in 2016
Concerned About ADHD symptoms?http://pageoverview.com/website-report/vyvanseadult.com
What are ADHD symptoms? Do ADHD symptoms differ by settings? Talk to your doctor. See Important Safety Information & Warning about Abuse and Dependence.
- Expected expiration: December 19th in 2017
- Creation date: December 19th in 2007
- Renew date: November 22nd in 2016
Shire: A Global Innovator in Specialty Biopharmaceuticalshttp://pageoverview.com/website-report/viropharma.com
Our purpose is to enable people with life-altering conditions to lead better lives. Explore our pioneering therapies, vision, and values at shire.com.
- Expected expiration: August 25th in 2017
- Creation date: August 26th in 1996
- Renew date: July 29th in 2016
- Google Plus Account: 116858740385185632622
Shire: A Global Innovator in Specialty Biopharmaceuticalshttp://pageoverview.com/website-report/shire.com
Our purpose is to enable people with life-altering conditions to lead better lives. Explore our pioneering therapies, vision, and values at shire.com.
- Expected expiration: November 6th in 2019
- Creation date: November 6th in 1999
- Renew date: September 7th in 2010
- Google Plus Account: 116858740385185632622
Treatment: ADHD & Moderate to Severe B.E.D. in Adultshttp://pageoverview.com/website-report/shireregistration.com
Find information on Vyvanse® (lisdexamfetamine dimesylate). Not for weight loss. See Important Safety Info & Warning About Abuse and Dependence.
- Expected expiration: December 11th in 2017
- Creation date: December 11th in 2013
- Renew date: November 17th in 2016
Shire: Leader Mondiale Nella Specialità Biopharmaceuticalshttp://pageoverview.com/website-report/shireitalia.it
Il nostro scopo è quello di consentire alle persone con condizioni di vita che alterano a condurre una vita migliore. Scopri i nostri terapie d'avanguardia, visione e valori a shire.com.
- Expected expiration: March 14th in 2018
- Creation date: December 13th in 2004
- Renew date: March 30th in 2017
Treatment: ADHD & Moderate to Severe B.E.D. in Adultshttp://pageoverview.com/website-report/vyvanse.com
Find information on Vyvanse® (lisdexamfetamine dimesylate). Not for weight loss. See Important Safety Info & Warning About Abuse and Dependence.
- Expected expiration: October 24th in 2017
- Creation date: October 24th in 2006
- Renew date: September 27th in 2016
Shire: The Leading Global Biotech Focused on Rare Diseaseshttp://pageoverview.com/website-report/dyax.com
Our purpose is to enable people with life-altering conditions to lead better lives. Explore our pioneering therapies, vision, and values at shire.com.
- Expected expiration: October 31st in 2019
- Creation date: November 1st in 1995
- Renew date: May 25th in 2016
- Google Plus Account: 116858740385185632622
Shire: líder global em biotecnologia focada em doenças rarashttp://pageoverview.com/website-report/shire.com.br
Na Shire, possibilitamos uma vida melhor às pessoas com condições que afetam sua maneira de viver.
- Expected expiration: October 21st in 2017
- Creation date: October 21st in 2007
- Renew date: September 21st in 2016
Binge Eating Disorder Facts and Informationhttp://pageoverview.com/website-report/bingeeatingdisorder.com
Binge eating disorder (B.E.D.) runs deeper than food. Talk to a doctor about symptoms and treatment options including therapy and nutritional counseling.
- Expected expiration: September 28th in 2018
- Creation date: September 28th in 2004
- Renew date: July 30th in 2014
Treatment: ADHD & Moderate to Severe B.E.D. in Adultshttp://pageoverview.com/website-report/theydotherest.com
Find information on Vyvanse® (lisdexamfetamine dimesylate). Not for weight loss. See Important Safety Info & Warning About Abuse and Dependence.
- Expected expiration: August 10th in 2017
- Creation date: August 10th in 2011
- Renew date: July 14th in 2016
Shire|夏尔中国官网http://pageoverview.com/website-report/shire.com.cn
Shire|夏尔中国官网:夏尔是专业为罕见病及其他专科疾病患者服务的全球领先生物科技公司，夏尔全球24000名员工长期致力于研发并提供突破性创新疗法，为患者提供终身受益的帮助以获得更加美好的生活。
- Creation date: May 28th in 2005
- Expected expiration: June 28th in 2018
- Google Plus Account: 116858740385185632622
ADHD in Childrenhttp://pageoverview.com/website-report/vyvansekids.com
Find information on ADHD in children (6-17). See Important Safety Information & Warning About Abuse and Dependence.
- Expected expiration: December 19th in 2017
- Creation date: December 19th in 2007
- Renew date: November 22nd in 2016
Shire Clinical Trials and Medical Research | ShireTrials.comhttp://pageoverview.com/website-report/shiretrials.com
Learn about Shire clinical research studies. We are recruiting patients for clinical trials and research focused on ADHD, angioedema and other conditions.
- Expected expiration: February 9th in 2019
- Creation date: February 9th in 2006
- Renew date: January 13th in 2018
Treatment: ADHD & Moderate to Severe B.E.D. in Adultshttp://pageoverview.com/website-report/udotherest.com
Find information on Vyvanse® (lisdexamfetamine dimesylate). Not for weight loss. See Important Safety Info & Warning About Abuse and Dependence.
- Expected expiration: June 21st in 2017
- Creation date: June 21st in 2011
- Renew date: May 25th in 2016
ホームhttp://pageoverview.com/website-report/shire.co.jp
- Creation date: December 17th in 2012
- Renew date: December 17th in 2012
Shire: The Leading Global Biotech Focused on Rare Diseaseshttp://pageoverview.com/website-report/npsp.com
Our purpose is to enable people with life-altering conditions to lead better lives. Explore our pioneering therapies, vision, and values at shire.com.
- Expected expiration: April 27th in 2018
- Creation date: April 26th in 1995
- Renew date: March 31st in 2017
- Google Plus Account: 116858740385185632622
Could I Have ADHD? | ADHDAdulthood.comhttp://pageoverview.com/website-report/adhdadulthood.com
Approximately 10.5 million US adults are estimated to have ADHD. Read more about ADHD symptoms, causes and treatment options here.
- Expected expiration: January 20th in 2018
- Creation date: January 20th in 2016
- Renew date: December 29th in 2016